logo

Merck & Co Inc. (MRK)



Trade MRK now with
  Date
  Headline
7/11/2018 6:50:16 AM FDA Grants Priority Review To Merck’s SBLA For KEYTRUDA
7/2/2018 6:49:39 AM FDA Grants Priority Review To Merck’s SBLA For KEYTRUDA In Combination With Chemotherapy
7/2/2018 6:33:29 AM Merck To Present New Data From Studies Of Investigational HIV Therapy Doravirine At AIDS 2018
7/2/2018 2:02:45 AM AstraZeneca And Merck Report Lynparza Approved In Japan For BRCA-mutated Metastatic Breast Cancer
7/2/2018 2:02:40 AM AstraZeneca And Merck: LYNPARZA Approved In Japan For BRCA-Mutated Metastatic Breast Cancer
6/27/2018 2:03:45 AM AstraZeneca And Merck Announce Positive Results From Phase 3 SOLO-1 Trial Of LYNPARZA Tablets
6/25/2018 6:32:02 AM FDA Accepts SBLA For Merck’s KEYTRUDA As Adjuvant Therapy In Advanced Melanoma
6/23/2018 11:55:39 AM Merck Reports Data From Comparative Trials With Sitagliptin Clinical Trials With JANUVIA
6/13/2018 6:45:58 AM FDA Grants Priority Review To Merck’s SBLA For GARDASIL®9